Elena Adams said she was put on temozolomide within days of being diagnosed with a brain tumour in 2016. Guidelines say the ...

Glioblastoma (GBM), one of the most aggressive types of brain cancer, is one of the greatest challenges for medicine, both ...

Elena Adams said she was put on temozolomide within days of being diagnosed with a brain tumour in 2016. Guidelines say the drug – which comes in tablet form – should be used on its own for up ...

VANCOUVER, Washington, March 18, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, ...

Dear Shareholders, As envisioned, 2025 is unfolding to be an exciting year for CytoDyn Inc. ("CytoDyn" or the "Company"). On February 24, 2025 ...

Three people will be charged after a man died from injuries when he was hit by a car, police said. Daniel Livingstone, 20, ...

a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with POH. The company is currently conducting a phase 2a trial of NEO100 in recurrent malignant glioma patients ...

which showed that Delytact boosted the one-year survival rate in patients with residual or recurrent glioblastoma who had been treated with radiotherapy and temozolomide chemotherapy and had one ...